Cangrelor — Expanding therapeutic options in patients with acute coronary syndrome
Cangrelor — Expanding therapeutic options in patients with acute coronary syndrome
About this item
Full title
Author / Creator
Kubica, Jacek , Adamski, Piotr , Dobrzycki, Sławomir , Gajda, Robert , Gąsior, Mariusz , Gierlotka, Marek , Jaguszewski, Miłosz , Legutko, Jacek , Lesiak, Maciej , Navarese, Eliano P. , Niezgoda, Piotr , Ostrowska, Małgorzata , Pawłowski, Tomasz , Tycińska, Agnieszka , Umińska, Julia M. , Witkowski, Adam and Gil, Robert
Publisher
Poland: Via Medica
Journal title
Language
English
Formats
Publication information
Publisher
Poland: Via Medica
Subjects
More information
Scope and Contents
Contents
Cangrelor is the only intravenous P2Y12 receptor antagonist. It is an adenosine triphosphate analog that selectively, directly, and reversibly binds to the platelet P2Y12 receptors exerting its antiaggregatory effect. Cangrelor is characterized by linear, dose-dependent pharmacokinetics and rapid onset of action providing potent platelet inhibition...
Alternative Titles
Full title
Cangrelor — Expanding therapeutic options in patients with acute coronary syndrome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919555
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919555
Other Identifiers
ISSN
1897-5593,1898-018X
E-ISSN
1898-018X
DOI
10.5603/cj.96076
